These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30098678)

  • 1. Advocating a Paradigm Shift in Health-State Valuations: The Estimation of Time-Preference Corrected QALY Tariffs.
    Jonker MF; Donkers B; de Bekker-Grob EW; Stolk EA
    Value Health; 2018 Aug; 21(8):993-1001. PubMed ID: 30098678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the Optimization of Bayesian D-Efficient Discrete Choice Experiment Designs for the Estimation of QALY Tariffs That Are Corrected for Nonlinear Time Preferences.
    Jonker MF; Bliemer MCJ
    Value Health; 2019 Oct; 22(10):1162-1169. PubMed ID: 31563259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Valuing SF-6D Health States Using a Discrete Choice Experiment.
    Norman R; Viney R; Brazier J; Burgess L; Cronin P; King M; Ratcliffe J; Street D
    Med Decis Making; 2014 Aug; 34(6):773-86. PubMed ID: 24025661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.
    Robinson A; Spencer A; Moffatt P
    Med Decis Making; 2015 Apr; 35(3):341-50. PubMed ID: 25349189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Not all respondents use a multiplicative utility function in choice experiments for health state valuations, which should be reflected in the elicitation format (or statistical analysis).
    Jonker MF; Norman R
    Health Econ; 2022 Feb; 31(2):431-439. PubMed ID: 34841637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
    Griebsch I; Coast J; Brown J
    Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Willingness to pay for a quality-adjusted life-year: the individual perspective.
    Bobinac A; Van Exel NJ; Rutten FF; Brouwer WB
    Value Health; 2010 Dec; 13(8):1046-55. PubMed ID: 20825620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient and public preferences for health states associated with AMD.
    Butt T; Dunbar HM; Morris S; Orr S; Rubin GS
    Optom Vis Sci; 2013 Aug; 90(8):855-60. PubMed ID: 23811607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of methods for converting DCE values onto the full health-dead QALY scale.
    Rowen D; Brazier J; Van Hout B
    Med Decis Making; 2015 Apr; 35(3):328-40. PubMed ID: 25398621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unchained melody: revisiting the estimation of SF-6D values.
    Craig BM
    Eur J Health Econ; 2016 Sep; 17(7):865-73. PubMed ID: 26359242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of contemporaneous EQ-5D and SF-6D responses using scoring algorithms derived from similar valuation exercises.
    Whitehurst DG; Norman R; Brazier JE; Viney R
    Value Health; 2014 Jul; 17(5):570-7. PubMed ID: 25128050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Portuguese value set for the SF-6D.
    Ferreira LN; Ferreira PL; Pereira LN; Brazier J; Rowen D
    Value Health; 2010 Aug; 13(5):624-30. PubMed ID: 20230545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health-related quality of life in economic evaluations for osteoporosis: whose values should we use?
    Gabriel SE; Kneeland TS; Melton LJ; Moncur MM; Ettinger B; Tosteson AN
    Med Decis Making; 1999; 19(2):141-8. PubMed ID: 10231076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health State Utilities for Patient's Current Health from Bipolar Type I Disorder.
    Banihashemian M; Rashidian A; Gholamian F; Parsaeian M; Moradi N; Amini H
    J Ment Health Policy Econ; 2018 Mar; 21(1):3-10. PubMed ID: 29643263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse probability weighted estimation of social tariffs: an illustration using the SF-6D value sets.
    Méndez I; Abellán Perpiñán JM; Sánchez Martínez FI; Martínez Pérez JE
    J Health Econ; 2011 Dec; 30(6):1280-92. PubMed ID: 21920617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Valuations of epilepsy-specific health states: a comparison of patients with epilepsy and the general population.
    Mulhern B; Rowen D; Snape D; Jacoby A; Marson T; Hughes D; Baker G; Brazier J
    Epilepsy Behav; 2014 Jul; 36():12-7. PubMed ID: 24836527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. US valuation of the SF-6D.
    Craig BM; Pickard AS; Stolk E; Brazier JE
    Med Decis Making; 2013 Aug; 33(6):793-803. PubMed ID: 23629865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are Health State Valuations from the General Public Biased? A Test of Health State Reference Dependency Using Self-assessed Health and an Efficient Discrete Choice Experiment.
    Jonker MF; Attema AE; Donkers B; Stolk EA; Versteegh MM
    Health Econ; 2017 Dec; 26(12):1534-1547. PubMed ID: 27790801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severity-Stratified Discrete Choice Experiment Designs for Health State Evaluations.
    Lim S; Jonker MF; Oppe M; Donkers B; Stolk E
    Pharmacoeconomics; 2018 Nov; 36(11):1377-1389. PubMed ID: 30030818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Corrective Approach: Policy Implications of Recent Developments in QALY Measurement Based on Prospect Theory.
    Lipman SA; Brouwer WBF; Attema AE
    Value Health; 2019 Jul; 22(7):816-821. PubMed ID: 31277829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.